CD44 and breast cancer: Consistently, Xing P et al. employed gain- and loss-of-function approaches in four different BC cell lines, showing that fascin expression promotes proliferation, enhances invasion potential, and enriches cancer stem cell-like features characterized by the CD44+/CD24- and EMT phenotype [16].